105 related articles for article (PubMed ID: 7531843)
1. Intraventricular administration of galanin does not affect behaviors associated with locus coeruleus activation in rats.
Holmes PV; Koprivica V; Chough E; Crawley JN
Peptides; 1994; 15(7):1303-8. PubMed ID: 7531843
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
[TBL] [Abstract][Full Text] [Related]
3. Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.
Foster SL; Galaj E; Karne SL; Ferré S; Weinshenker D
Addict Biol; 2021 Sep; 26(5):e13037. PubMed ID: 33768673
[TBL] [Abstract][Full Text] [Related]
4. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
5. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
Hong M; Milne B; Jhamandas K
Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
8. Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress.
Xu GP; Van Bockstaele E; Reyes B; Bethea T; Valentino RJ
J Neurosci; 2004 Sep; 24(38):8193-7. PubMed ID: 15385601
[TBL] [Abstract][Full Text] [Related]
9. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus.
Page ME; Abercrombie ED
Synapse; 1999 Sep; 33(4):304-13. PubMed ID: 10421711
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus.
Butler PD; Weiss JM; Stout JC; Nemeroff CB
J Neurosci; 1990 Jan; 10(1):176-83. PubMed ID: 2299391
[TBL] [Abstract][Full Text] [Related]
11. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
Rasmussen K; Hsu MA; Vandergriff J
Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
Esposito E; Kruszewska A; Ossowska G; Samanin R
Psychopharmacology (Berl); 1987; 93(3):393-6. PubMed ID: 3124170
[TBL] [Abstract][Full Text] [Related]
13. Activation of galanin receptor 1 inhibits locus coeruleus neurons via GIRK channels.
Bai YF; Ma HT; Liu LN; Li H; Li XX; Yang YT; Xue B; Wang D; Xu ZD
Biochem Biophys Res Commun; 2018 Sep; 503(1):79-85. PubMed ID: 29852172
[TBL] [Abstract][Full Text] [Related]
14. NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal.
Javelle N; Bérod A; Renaud B; Lambás-Señas L
Neuroreport; 2002 Apr; 13(5):725-8. PubMed ID: 11973478
[TBL] [Abstract][Full Text] [Related]
15. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal.
Rasmussen K; Vandergriff J
Neuropharmacology; 2003 Jan; 44(1):88-92. PubMed ID: 12559125
[TBL] [Abstract][Full Text] [Related]
16. The primate locus coeruleus and effects of clonidine on opiate withdrawal.
Redmond DE; Huang YH
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):25-9. PubMed ID: 6282817
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
18. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
[TBL] [Abstract][Full Text] [Related]
19. Galanin enhances noradrenaline-induced outward current on locus coeruleus noradrenergic neurons.
Xu ZQ; Tong YG; Hökfelt T
Neuroreport; 2001 Jun; 12(8):1779-82. PubMed ID: 11409758
[TBL] [Abstract][Full Text] [Related]
20. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation.
Grant SJ; Huang YH; Redmond DE
Pharmacol Biochem Behav; 1988 May; 30(1):13-9. PubMed ID: 3174735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
